Immunisation of colorectal cancer patients with autologous tumour cells

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 823-826

  Diederichsen, Axel C P ^a   Stenholm, Anna C O ^b   Kronborg, Ole ^a   Fenger, Claus ^a   Jensenius, Jens Christian ^c   Zeuthen, Jesper ^b   Kristensen, Tom ^a   Christensen, Per B ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d Funen Hospital   (Denmark)

Author keywords

CD80; Colorectal cancer; HLA class II; Tumour vaccines

Indexed keywords

B7 ANTIGEN; BCG VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; TUMOR CELL VACCINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CLONAL ANERGY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

EID: 0031867430     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.823     Document Type: Article

References (11)

1. Pihl J and Bandt B: Cancer incidence in Denmark 1994. The Danish National Board of Health, Copenhagen, pp2-5, 1997.
2. Johansen C, Soll Johanning H, Kolstad H, Lynge E and Carstensen B: Survival of Danish cancer patients 1943-1987. Digestive organs. APMIS 33 (Suppl.): 35-76, 1993.
3. Connors TA, Duncan R and Knox RJ: The chemotherapy of colon cancer. Eur J Cancer 31 A: 1373-1378, 1995.
4. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336: 980-987, 1997.
5. Lindemann F, Schlimok G, Dirschedl P, Witte J and Riethmüller G: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689, 1992.
6. Hoover HC Jr, Brandhorst JS, Peters LC, Surdyke MG, Takeshita Y, Madariaga J, Muenz LR and Hanna MG Jr: Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 11: 390-399, 1993.
7. Diederichsen ACP, Hansen TP, Nielsen O, Fenger C, Jensenius JC, Christensen PB, Kristensen T and Zeuthen J: A comparison of flow cytometry and immunohistochemistry in human colorectal cancers. APMIS (In press).
8. Ransom JH, Pelle B and Hanna MG Jr: Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy. Cancer Res 52: 3460-3466, 1992.
9. Diederichsen ACP, Olsen AC, Kronborg O, Fenger C, Jensenius JC, Zeuthen J, Christensen PB and Kristensen T: Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers. Int J Cancer (In press).
10. Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 248: 1349-1356, 1990.
11. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P and Linsley PS: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4. Cell 71: 1093-1102, 1992.